Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Eledon Pharmaceuticals Inc fell by 51.80m. Cash Flow from Financing totalled 33.02m or -- of revenues. In addition the company used 39.53m for operations while cash used for investing totalled 45.29m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.2208 |
---|---|
Tangible book value per share | -1.06 |
More ▼
Balance sheet in USDView more
Current ratio | 14.48 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼